163 related articles for article (PubMed ID: 24524559)
1. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
[No Abstract] [Full Text] [Related]
2. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
Fernandez-Flores A
Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
[No Abstract] [Full Text] [Related]
4. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
5. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
[TBL] [Abstract][Full Text] [Related]
6. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
[TBL] [Abstract][Full Text] [Related]
8. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
9. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
Honma M; Kato N; Hashimoto M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
Biesterfeld S; Josef J
Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
[TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
Youssef RF; Shariat SF; Kapur P; Kabbani W; Ghoneim T; King E; Cockburn A; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
Hum Pathol; 2011 Mar; 42(3):347-55. PubMed ID: 21111452
[TBL] [Abstract][Full Text] [Related]
13. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
Ichikawa E; Ohnishi T; Watanabe S
J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
[No Abstract] [Full Text] [Related]
14. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous basal cell carcinoma with dual differentiation into squamous cell carcinoma and spindle cell squamous cell carcinoma: a case report with immunohistochemical studies.
Terada T
Dermatol Surg; 2013 Jan; 39(1 Pt 1):130-2. PubMed ID: 23227812
[No Abstract] [Full Text] [Related]
16. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
17. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
18. Proliferative characterization of basal-cell carcinoma and trichoepithelioma in small biopsy specimens.
Lum CA; Binder SW
J Cutan Pathol; 2004 Sep; 31(8):550-4. PubMed ID: 15268710
[TBL] [Abstract][Full Text] [Related]
19. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
Vasiljević N; Andersson K; Bjelkenkrantz K; Kjellström C; Månsson H; Nilsson E; Landberg G; Dillner J; Forslund O
Int J Cancer; 2009 May; 124(10):2361-6. PubMed ID: 19165861
[TBL] [Abstract][Full Text] [Related]
20. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]